Vincent Vultaggio - 08 Jan 2026 Form 4 Insider Report for Zentalis Pharmaceuticals, Inc. (ZNTL)

Role: PAO and PFO
Signature: /s/ James B. Bucher, attorney-in-fact for Vincent Vultaggio
Issuer symbol: ZNTL
Transactions as of: 08 Jan 2026
Net transactions value: $0
Form type: 4
Filing time: 09 Jan 2026, 20:36:10 UTC
Previous filing: 05 Feb 2025
Next filing: 04 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Vultaggio Vincent	PAO and PFO	C/O ZENTALIS PHARMACEUTICALS, INC., 10275 SCIENCE CENTER DRIVE, SUITE 200, SAN DIEGO	/s/ James B. Bucher, attorney-in-fact for Vincent Vultaggio	09 Jan 2026	0002018766

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ZNTL	Stock Option (Right to Buy)	Award	$0	+100,000		$0.000000	100,000	08 Jan 2026	Stock Option	100,000	$2.84	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The options will vest over four years in substantially equal monthly installments until the options are fully vested, subject to the Reporting Person's continued service with the Issuer.

Remarks:

Exhibit 24 - Power of Attorney